IMCR ▼ -0.3% - Immunocore Holdings plc
$IMCR - Immunocore will present Phase 1 data for brenetafusp plus KIMMTRAK® (tebentafusp-tebn) in metastatic uveal melanoma, during a late-breaking oral session at the 2026 SITC meeting
29-OCT-2026 09:00 AM ET
Share this post
More filings for $IMCR
IMCR - Immunocore Holdings plc - SEC Filing Update (07-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 7, 2026IMCR ▼ -0.1% - Immunocore Holdings plcSep 1, 2026IMCR - Immunocore Holdings plc - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026IMCR - Immunocore Holdings plc - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 6, 2026
View full $IMCR filing history →💬 Comments
Loading comments…
Leave a comment